Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

Similar articles for PubMed (Select 23044041)

1.

Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance.

Ke CJ, Chiang WL, Liao ZX, Chen HL, Lai PS, Sun JS, Sung HW.

Biomaterials. 2013 Jan;34(1):1-10. doi: 10.1016/j.biomaterials.2012.09.023. Epub 2012 Oct 6.

PMID:
23044041
2.

Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.

Deng L, Li L, Yang H, Li L, Zhao F, Wu C, Liu Y.

J Nanosci Nanotechnol. 2014 Apr;14(4):2947-54.

PMID:
24734715
3.

Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.

Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ.

Nanotechnology. 2012 Dec 14;23(49):495103. doi: 10.1088/0957-4484/23/49/495103. Epub 2012 Nov 13.

PMID:
23149859
4.

Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.

Li B, Xu H, Li Z, Yao M, Xie M, Shen H, Shen S, Wang X, Jin Y.

Int J Nanomedicine. 2012;7:187-97. doi: 10.2147/IJN.S27864. Epub 2012 Jan 9.

5.

Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.

Qiu L, Li Z, Qiao M, Long M, Wang M, Zhang X, Tian C, Chen D.

Acta Biomater. 2014 May;10(5):2024-35. doi: 10.1016/j.actbio.2013.12.025. Epub 2013 Dec 21.

PMID:
24365705
6.

Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Förster resonance energy transfer.

Chen KJ, Chiu YL, Chen YM, Ho YC, Sung HW.

Biomaterials. 2011 Apr;32(10):2586-92. doi: 10.1016/j.biomaterials.2010.11.069. Epub 2011 Jan 19.

PMID:
21251711
7.

Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments.

Ke CJ, Su TY, Chen HL, Liu HL, Chiang WL, Chu PC, Xia Y, Sung HW.

Angew Chem Int Ed Engl. 2011 Aug 22;50(35):8086-9. doi: 10.1002/anie.201102852. Epub 2011 Jul 12.

PMID:
21751316
8.

Effects of surfactants on the properties of PLGA nanoparticles.

Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT.

J Biomed Mater Res A. 2012 Aug;100(8):1998-2005. doi: 10.1002/jbm.a.34040. Epub 2012 May 5.

PMID:
22566409
10.

Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.

Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z.

Biomaterials. 2012 Oct;33(28):6877-88. doi: 10.1016/j.biomaterials.2012.06.019. Epub 2012 Jul 6.

PMID:
22770799
11.

Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.

Li F, Sun J, Zhu H, Wen X, Lin C, Shi D.

Colloids Surf B Biointerfaces. 2011 Nov 1;88(1):58-62. doi: 10.1016/j.colsurfb.2011.06.003. Epub 2011 Jun 25.

PMID:
21764271
12.

Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.

Wang YC, Wang F, Sun TM, Wang J.

Bioconjug Chem. 2011 Oct 19;22(10):1939-45. doi: 10.1021/bc200139n. Epub 2011 Sep 9.

PMID:
21866903
13.

PLGA/polymeric liposome for targeted drug and gene co-delivery.

Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J.

Biomaterials. 2010 Nov;31(33):8741-8. doi: 10.1016/j.biomaterials.2010.07.082. Epub 2010 Aug 19.

PMID:
20727587
14.

Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.

Lee H, Ahn CH, Park TG.

Macromol Biosci. 2009 Apr 8;9(4):336-42. doi: 10.1002/mabi.200800229.

PMID:
19006195
15.

Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.

Misra R, Sahoo SK.

Mol Pharm. 2011 Jun 6;8(3):852-66. doi: 10.1021/mp100455h. Epub 2011 Apr 15. Erratum in: Mol Pharm. 2013 Dec 2;10(12):4746.

PMID:
21480667
16.

Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

Wang F, Wang YC, Dou S, Xiong MH, Sun TM, Wang J.

ACS Nano. 2011 May 24;5(5):3679-92. doi: 10.1021/nn200007z. Epub 2011 Apr 12.

PMID:
21462992
17.

Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.

Han S, Liu Y, Nie X, Xu Q, Jiao F, Li W, Zhao Y, Wu Y, Chen C.

Small. 2012 May 21;8(10):1596-606. doi: 10.1002/smll.201102280. Epub 2012 Mar 13.

PMID:
22411637
18.

Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.

Chavanpatil MD, Patil Y, Panyam J.

Int J Pharm. 2006 Aug 31;320(1-2):150-6. Epub 2006 Apr 7.

PMID:
16713148
19.

Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.

Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.

Nanomedicine. 2007 Dec;3(4):246-57.

PMID:
18068091
20.

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.

Li R, Wu R, Zhao L, Wu M, Yang L, Zou H.

ACS Nano. 2010 Mar 23;4(3):1399-408. doi: 10.1021/nn9011225.

PMID:
20148593
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk